FMP
Acurx Pharmaceuticals, Inc.
ACXP
NASDAQ
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
2.02 USD
-0.01 (-0.495%)
About
ceo
Mr. David P. Luci CPA, Esq., J.D.
sector
Healthcare
industry
Biotechnology
website
https://www.acurxpharma.com
exchange
NASDAQ
Description
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.
CIK
0001736243
ISIN
US00510M1045
CUSIP
00510M104
Address
259 Liberty Avenue
Phone
917-533-1469
Country
US
Employee
4
IPO Date
Jun 25, 2021
Summary
CIK
0001736243
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
00510M104
ISIN
US00510M1045
Country
US
Price
2.02
Beta
-1.9
Volume Avg.
100.85k
Market Cap
31.83M
Shares
-
52-Week
1.17-8.82
DCF
0.59
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-1.76
P/B
-
Website
https://www.acurxpharma.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ACXP News
It looks like there's no news available.
